Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

The U.S. agency that oversees Medicare is taking out questions on enrollment application forms that ask people about their ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Some people have taken ivermectin, including forms of the drug prescribed for animals, to treat or prevent COVID-19. But ivermectin isn’t Food and Drug Administration (FDA) approved for these ...

Drug strengths in the table are in micrograms ... Talk with your doctor or pharmacist for information about other forms ivermectin comes in. Your doctor may recommend taking ivermectin with ...

Pimentel, 36, was arraigned in court on Wednesday after pleading not guilty to drug trafficking and firearm violation charges ...

This story was originally published by Healthbeat. Sign up for their public health newsletters at healthbeat.org/newsletters.

A small and financially opaque drug research nonprofit group based in Ohio has managed to get its research cited extensively in high-prestige publications such as the New York Times, Wall Street ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.